In DLBCL, mutation of SGK1 may lead to its loss of function, rendering lymphoma cells more sensitive to glucocorticoids, chemotherapy drugs, and radiotherapy, thereby improving prognosis. The gene discussed is SGK1; the disease is lymphoma.